Delivery Order SPE2DB24D6044-SPE2DB24FLGZW
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The award, valued at $35,517.52, has an ultimate completion date of April 1, 2024. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government, is for the delivery of RABAVERT rabies vaccine with diluents. The $1,158.18 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 26, 2024 with a completion date of June 27, 2024. The contract does not have a set-aside designation. AmerisourceBergen also holds a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,198.20 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract is to provide RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,399.00 delivery order contract is for the provision of RABAVERT rabies vaccine with diluents. The contract has a firm fixed price pricing type and a completion date of July 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,895.45 firm fixed-price delivery order is for the supply of RABAVERT Rabies Vaccine with diluents, with a completion date of September 12, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,158.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution services company. The contract is for the delivery of RABAVERT rabies vaccine with diluents. This is a firm fixed price delivery order contract with a performance period through March 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a child contract...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $9,651.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor. The contract is a delivery order for RABAVERT rabies vaccine with diluents, with a period of performance through March 11, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. This award is associated with a larger indefinite delivery contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.15, is for the delivery of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of March 19, 2025 and is a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $41,916.00, is a delivery order contract for the supply of RABAVERT rabies vaccine with diluents. The contract has a final completion date of January 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...